Alfa Scientific Designs, Inc.

Alfa Scientific Designs, Inc. specializes in rapid immunochemical test kits designed for clinical and point-of-care use. Their portfolio includes urine cassettes and cup tests for detecting drugs of abuse (such as methamphetamine, cocaine, cannabinoids, and opiates), faecal occult blood, and human chorionic gonadotropin (hCG) for pregnancy testing. These tests are formulated to provide immediate visual results, often used in settings like emergency rooms, clinics, or law enforcement for quick screening.

Alfa Scientific Designs, Inc. is based in the United States. Their devices are authorized for use in the U.S., where they are listed in regulatory databases such as the FDA’s 510(k) and Unique Device Identifier (UDI) systems. These registries track submissions for devices that have undergone the necessary regulatory pathways to demonstrate safety and performance.

The devices produced by Alfa Scientific Designs, Inc. fall into three classification categories under FDA regulations: Class I (generally low-risk devices with minimal regulatory controls), Class II (devices requiring special controls to ensure safety and effectiveness), and unclassified (U) devices, which may require additional evaluation or have unique risk profiles. Classification depends on factors like the device’s intended use, potential risks, and the nature of the test results.

The devices manufactured by Alfa Scientific Designs, Inc. are listed in the FDA’s 510(k) Premarket Notification database and the Unique Device Identifier (UDI) system. The 510(k) registry tracks submissions for devices that claim substantial equivalence to a legally marketed predicate device, while the UDI system ensures standardized identification of medical devices for tracking, traceability, and regulatory compliance purposes.

Alfa Scientific Designs, Inc. offers rapid immunochemical tests for fertility screening, specifically human chorionic gonadotropin (hCG) detection, which is commonly used in pregnancy testing. They also provide faecal occult blood tests, which are designed for early detection of potential gastrointestinal issues. These tests are formulated for point-of-care use, delivering quick results to aid in clinical decision-making.